Search for: "Sabatelli"
Results 1 - 20
of 45
Sort by Relevance
|
Sort by Date
28 Aug 2022, 8:51 pm
Sabatelli** -- Decades after the science-fiction visions of Stanley Kubrick’s 2001: A Space Odyssey and Isaac Asimov’s I, Robot, artificial intelligence ("AI") is finally moving to the mainstream. [read post]
8 Oct 2021, 1:53 pm
We blogged about the Sabatelli decision on . [read post]
8 Oct 2021, 1:53 pm
We blogged about the Sabatelli decision on Oct. 28, 2020. [read post]
9 Nov 2020, 6:00 am
In Sabatelli v. [read post]
28 Oct 2020, 3:55 pm
In Sabatelli v. [read post]
17 Mar 2019, 9:59 pm
Sabatelli** As reviewed previously, antibody-drug conjugates (ADCs) are a highly promising class of antitumor drugs that represent a growing proportion of cancer treatments in the development pipeline (see "Antibody Drug Conjugates: The Patent Landscape for a New Class of Cancer Treatment"). [read post]
3 Mar 2019, 9:28 pm
Sabatelli** -- Lowering carbon dioxide (CO2) levels in our atmosphere is one of the most important challenges to be overcome in the next century. [read post]
28 Jan 2019, 9:34 pm
By Brittany Knight* and Anthony Sabatelli** -- The past year was a big year for FDA approved new drugs and biologics -- 59 in fact, compared to 46 in 2017 and a mere 22 in 2016. [read post]
9 Jan 2019, 9:59 pm
Sabatelli** -- As discussed in our previous article, antibody-drug conjugates (ADCs) have emerged as a highly promising class of anti-cancer drugs, and significant technical innovations are being made in all three components of the ADC, i.e., the antibody, the drug payload, and the linker joining them. [read post]
13 Dec 2018, 9:36 pm
By Brittany Knight* and Anthony Sabatelli** -- Software is a generic term to refer to a collection of data or executing code used by a computer to implement arithmetic operations or logical operations. [read post]
3 Oct 2018, 9:55 pm
Sabatelli** -- Typically, we think of patents as the main tool that allows for product exclusivity in the pharmaceutical industry. [read post]
5 Sep 2018, 9:59 pm
Sabatelli** -- The global hair coloring product market is projected to grow into a 200 billion-dollar industry by 2025. [read post]
12 Aug 2018, 8:54 pm
Sabatelli** -- Over the last decade, antibody-drug conjugates (ADCs) have emerged as a highly promising new class of biopharmaceuticals. [read post]
19 Jul 2018, 8:28 pm
Sabatelli**, and Jonathan Schuchardt*** -- Buried amidst the flurry of recent Federal Circuit subject matter eligibility decisions is a question that could significantly change how Section 101 is applied in patent litigation. [read post]
21 Jun 2018, 9:59 pm
Sabatelli** -- "Your hair is your crowning glory" is an often-quoted phrase with biblical roots.1 Perhaps more importantly, one's hair is a visible barometer of one's health and age. [read post]
6 Jun 2018, 8:59 pm
Sabatelli** -- Nanoparticles have been used in cancer and other diseases as both diagnostics and therapeutic agents; for example, magnetic nanoparticles for theranostics, quantum dots for bioimaging, nanoparticles as cancer biomarkers and for cancer therapy, and nanoparticles as drug delivery carriers. [read post]
3 May 2018, 9:29 pm
Sabatelli** -- The cosmeceutical industry is ever more competitive and continues to grow with a myriad of new cosmeceutical products entering the market every day. [read post]
20 Dec 2017, 9:53 pm
Sabatelli** -- Clarity on patent subject matter eligibility is still being sought five years after Mayo [1] and three years after Alice [2]. [read post]
11 Oct 2017, 8:46 am
Steve Brachmann: PTAB Due Process Violations Raised In Brief To Federal Circuit Joe Mullin: New Patent-Holder Grabs Nokia Patents, Sues Over Apple iPhones Michael Hinrichsen & Anthony Sabatelli: Patent Exhaustion And Pharmaceuticals Jo Dale Carothers: Federal Circuit Clarifies Venue Requirements For Patent Cases Florian Mueller: DoJ Backs Apple, Says Supreme Court Should Deny Samsung’s Most Recent Cert Petition Upcoming Events The Power Of The PTAB: The New Authority In Patent Law… [read post]
10 Oct 2017, 9:59 pm
Sabatelli** -- On May 30th, the Supreme Court ruled in Impression Products, Inc. v. [read post]
